Atlas Trials

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Clinical trial NCT02296684 · COMPLETED

Trial details

NCT number
NCT02296684
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Cancer of Head and NeckHead and Neck CancerNeoplasms, Head and NeckCarcinoma, Squamous Cell of Head and NeckSquamous Cell Carcinoma of the Head and NeckSquamous Cell Carcinoma, Head and Neck
Start date
2015-03-25
Primary completion
2022-04-05
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.